Thus, although additional studies will be necessary to dissect the molecular pathways involved in the transdifferentiation program initiated by ILK depletion, our study is the first to show the involvement of ILK in EndMT in the setting of CAVD development. The gene discussed is ILK; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.